CVE-2023-41088 — MEDIUM (6.3)

Vulnerability Description

The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.

CVSS Score

6.3

MEDIUM

CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N

Attack Vector

ADJACENT_NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

UNCHANGED

Confidentiality

HIGH

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Dexma	Dexgate	20130114

Related Weaknesses (CWE)

CWE-319

References

https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party AdvisoryUS Government Resource
https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party AdvisoryUS Government Resource

FAQ

What is CVE-2023-41088?

CVE-2023-41088 is a vulnerability with a CVSS score of 6.3 (MEDIUM). The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to t...

How severe is CVE-2023-41088?

CVE-2023-41088 has been rated MEDIUM with a CVSS base score of 6.3/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-41088?

Check the references section above for vendor advisories and patch information. Affected products include: Dexma Dexgate.